Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperfractionated craniospinal radiation in medulloblastoma

M H Marymont1, J Geohas, T Tomita

  • 1Radiation Oncology Center, Northwestern Memorial Hospital, Chicago, IL 60611, USA.

Pediatric Neurosurgery
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consistent and effective method to define the mouse estrous cycle stage by a deep learning-based model.

The Journal of endocrinology·2024
Same author

[Urinary stress incontinence after radical prostatectomy in treatment reality : Results of a rehabilitation clinic-2009 compared to 2016].

Urologie (Heidelberg, Germany)·2022
Same author

Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes.

The British journal of dermatology·2020
Same author

The lack of HSD17B3 in male mice results in disturbed Leydig cell maturation and endocrine imbalance akin to humans with HSD17B3 deficiency.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2020
Same author

Insights into the role of androgen receptor in human testicular peritubular cells.

Andrology·2018
Same author

Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Hyperfractionated craniospinal radiotherapy (HFxRT) is a feasible treatment for pediatric medulloblastoma and other brain tumors. This approach shows favorable survival outcomes, warranting further investigation in larger trials.

Area of Science:

  • Pediatric Oncology
  • Radiation Oncology
  • Neuro-oncology

Background:

  • Medulloblastoma and primitive neuroectodermal tumors (PNTs) are aggressive pediatric brain cancers.
  • Conventional radiotherapy techniques may have limitations in efficacy and toxicity for these challenging conditions.

Purpose of the Study:

  • To assess the feasibility and preliminary outcomes of hyperfractionated craniospinal radiotherapy (HFxRT) in children with medulloblastoma or PNTs.
  • To evaluate the efficacy and toxicity profile of this novel radiation strategy.

Main Methods:

  • A pilot study involving 13 pediatric patients treated between 1986 and 1991.
  • Patients were divided into three groups based on prior treatment and extent of surgical resection.
  • HFxRT doses varied: 64.8 Gy (primary)/31.2 Gy (craniospinal axis) for Group I, 72 Gy (primary)/34 Gy (craniospinal axis) for Group II, and 60 Gy (primary)/26 Gy (craniospinal axis) for Group III.

Related Experiment Videos

Main Results:

  • 64% of patients in Groups I and II (11 patients) achieved durable remission without recurrence.
  • Two of three Group I patients and five of seven Group II patients remained recurrence-free.
  • One patient achieved long-term survival after salvage bone marrow transplant following local failure.

Conclusions:

  • HFxRT is a feasible radiation strategy for pediatric medulloblastoma and PNTs.
  • Favorable survival results suggest potential for improved outcomes in these young patients.
  • Further evaluation in a Phase-III randomized trial is recommended to confirm these findings.